Medicamen Biotech Ltd (MEDICAMEQ) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 770569, "name": "Medicamen Biotec", "stock_name": "Medicamen Biotec", "full_name": "Medicamen Biotech Ltd", "name_url": "stocks-analysis/medicamen-biotec", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "251.60", "chg": -9.4, "chgp": "-3.6%", "dir": -1, "prev_price": "261.00", "mcapval": "359.00 Cr", "mcap": "Micro Cap", "scripcode": 531146, "symbol": "MEDICAMEQ", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE646B01010", "curr_date": "Mar 20", "curr_time": "", "bse_nse_vol": "39.37 k", "exc_status": "Active", "traded_date": "Mar 20, 2026", "traded_date_str": "2026 03 20", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/medicamen-biotec-770569-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Medicamen Biotech Ltd Falls to 52-Week Low of Rs 260.3 as Sell-Off Deepens", "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-stock-falls-to-52-week-low-of-rs2603-3903030", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicamenBiotec_priceRelatedfactors_3903030.png", "date": "2026-03-20 11:13:53", "description": "For the second consecutive session, Medicamen Biotech Ltd has seen its share price decline, hitting a fresh 52-week low of Rs 260.3 on 20 Mar 2026. This latest drop extends the stock’s downward trajectory, which has now resulted in a 3.93% loss over the past two days, underperforming its sector by 1.51% today." }, { "title": "Medicamen Biotech Ltd Falls to 52-Week Low of Rs.262.5 Amidst Continued Downtrend", "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-falls-to-52-week-low-of-rs2625-amidst-continued-downtrend-3900282", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicamenBiotec_priceRelatedfactors_3900282.png", "date": "2026-03-19 10:19:13", "description": "Medicamen Biotech Ltd’s shares declined to a fresh 52-week low of Rs.262.5 on 19 Mar 2026, marking a significant drop amid broader market weakness and company-specific performance concerns. The stock underperformed its sector and key benchmarks, reflecting ongoing challenges in sustaining growth momentum." }, { "title": "Medicamen Biotech Ltd Falls to 52-Week Low of Rs.263.65", "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-falls-to-52-week-low-of-rs26365-3893685", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicamenBiotec_priceRelatedfactors_3893685.png", "date": "2026-03-16 11:20:15", "description": "Medicamen Biotech Ltd has reached a new 52-week low of Rs.263.65 today, marking a significant decline in its stock price amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial performance and valuation metrics." }, { "title": "Medicamen Biotech Ltd Falls 5.93%: 3 Key Factors Driving the Weekly Decline", "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-falls-593-3-key-factors-driving-the-weekly-decline-3891110", "imagepath": "", "date": "2026-03-14 13:05:09", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Mar 09:</strong> Stock opens week at Rs.285.50, down 2.06%</p>\n <p><strong>Mar 12:</strong> Hits 52-week low of Rs.275.95 amid sector weakness</p>\n <p><strong>Mar 13:</strong> New 52-week low at Rs.270, valuation shifts signal renewed price attractiveness</p>\n <p><strong>Mar 13:</strong> Week closes at Rs.274.20, down 0.31% on the day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.285.50</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat..." }, { "title": "Medicamen Biotech Ltd Stock Hits 52-Week Low at Rs.270", "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-stock-hits-52-week-low-at-rs270-3888761", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicamenBiotec_priceRelatedfactors_3888761.png", "date": "2026-03-13 10:01:48", "description": "Medicamen Biotech Ltd’s shares declined to a fresh 52-week low of Rs.270 on 13 Mar 2026, marking a significant downturn amid broader market weakness and persistent underperformance relative to its sector and benchmark indices." }, { "title": "Medicamen Biotech Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Market Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-valuation-shifts-signal-renewed-price-attractiveness-amid-market-challenges-3888008", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicamenBiotec_valuationdot_3888008.png", "date": "2026-03-13 08:00:46", "description": "Medicamen Biotech Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating despite ongoing challenges in the Pharmaceuticals & Biotechnology sector. The company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios, alongside other key financial metrics, reveal a complex picture of valuation attractiveness contrasted with operational and market headwinds." }, { "title": "Medicamen Biotech Ltd Falls to 52-Week Low of Rs.275.95", "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-falls-to-52-week-low-of-rs27595-3887222", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicamenBiotec_priceRelatedfactors_3887222.png", "date": "2026-03-12 15:06:52", "description": "Medicamen Biotech Ltd’s shares declined to a fresh 52-week low of Rs.275.95 on 12 Mar 2026, marking a significant downturn amid broader market weakness and company-specific performance concerns. The stock has underperformed its sector and key benchmarks, reflecting ongoing pressures in the Pharmaceuticals & Biotechnology space." }, { "title": "Medicamen Biotech Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/medicamen-biotech-ltd-is-rated-strong-sell-3882502", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicamenBiotec_mojoScore_3882502.png", "date": "2026-03-10 10:10:18", "description": "Medicamen Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 February 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are based on the company’s current position as of 10 March 2026, providing investors with the latest comprehensive view of the stock’s performance and prospects." }, { "title": "Medicamen Biotech Ltd Stock Falls to 52-Week Low of Rs.277.05", "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-stock-falls-to-52-week-low-of-rs27705-3864809", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicamenBiotec_priceRelatedfactors_3864809.png", "date": "2026-03-02 12:25:48", "description": "Medicamen Biotech Ltd’s share price declined sharply to a new 52-week low of Rs.277.05 today, marking a significant downturn amid broader market fluctuations. The stock opened with an 8% gap down and has now fallen for two consecutive sessions, underperforming its sector and the broader market indices." } ], "total": 6224, "sid": "770569", "stock_news_url": "https://www.marketsmojo.com/news/medicamen-biotech-770569" }, "announcements": [ { "caption": "Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations 2015", "datetime": "21-Feb-2026", "details": "The company has on 27.01.2026 received a cautionery letter (Email) from NSE for observations reported by the Secretarial Auditor in ASCR for FY ended 31.03.2025.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Change in Management", "datetime": "18-Feb-2026", "details": "Corrigendum- Intimation regarding completion of term of Independent Directorship of Mr Harish Pande and Mr Arun Kumar", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "16-Feb-2026", "details": "Announcement under Regulation 30 (LODR) - Newspaper Publication", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Medicamen Biotech Ltd has declared <strong>10%</strong> dividend, ex-date: 19 Sep 25", "dt": "2025-09-19", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Mar 09: Stock opens week at Rs.285.50, down 2.06%

Mar 12: Hits 52-week low of Rs.275.95 amid sector weakness

Mar 13: New 52-week low at Rs.270, valuation shifts signal renewed price attractiveness

Mar 13: Week closes at Rs.274.20, down 0.31% on the day

Week Open

Rs.285.50

Week Close

Read full news article

Medicamen Biotech Ltd Stock Hits 52-Week Low at Rs.270

2026-03-13 10:01:48

Medicamen Biotech Ltd’s shares declined to a fresh 52-week low of Rs.270 on 13 Mar 2026, marking a significant downturn amid broader market weakness and persistent underperformance relative to its sector and benchmark indices.

Read full news article

Medicamen Biotech Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Market Challenges

2026-03-13 08:00:46

Medicamen Biotech Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating despite ongoing challenges in the Pharmaceuticals & Biotechnology sector. The company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios, alongside other key financial metrics, reveal a complex picture of valuation attractiveness contrasted with operational and market headwinds.

Read full news article

Medicamen Biotech Ltd Falls to 52-Week Low of Rs.275.95

2026-03-12 15:06:52

Medicamen Biotech Ltd’s shares declined to a fresh 52-week low of Rs.275.95 on 12 Mar 2026, marking a significant downturn amid broader market weakness and company-specific performance concerns. The stock has underperformed its sector and key benchmarks, reflecting ongoing pressures in the Pharmaceuticals & Biotechnology space.

Read full news article

Medicamen Biotech Ltd is Rated Strong Sell

2026-03-10 10:10:18

Medicamen Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 February 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are based on the company’s current position as of 10 March 2026, providing investors with the latest comprehensive view of the stock’s performance and prospects.

Read full news article

Medicamen Biotech Ltd Stock Falls to 52-Week Low of Rs.277.05

2026-03-02 12:25:48

Medicamen Biotech Ltd’s share price declined sharply to a new 52-week low of Rs.277.05 today, marking a significant downturn amid broader market fluctuations. The stock opened with an 8% gap down and has now fallen for two consecutive sessions, underperforming its sector and the broader market indices.

Read full news article